Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Foltin

Showing results (411-420 of 413) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 413 results.
Nature Medicine|June 8, 2023
Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized trialsMargaret Haney, Monique Vallée, Sandy Fabre, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 42

Showing results (411-420 of 413) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 413 results.
Nature Medicine|June 8, 2023
Signaling-specific inhibition of the CB<sub>1</sub> receptor for cannabis use disorder: phase 1 and phase 2a randomized trialsMargaret Haney, Monique Vallée, Sandy Fabre, et al.
Pain|October 24, 2013
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendationsAlec B O'Connor, Dennis C Turk, Robert H Dworkin, et al.
Pain|September 25, 2012
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsSandra D Comer, James P Zacny, Robert H Dworkin, et al.
Pageof 42